Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tim A. C. de Vries"'
Autor:
Eva R. Meulendijks, Rushd F. M. Al-Shama, Makiri Kawasaki, Benedetta Fabrizi, Jolien Neefs, Robin Wesselink, Auriane C. Ernault, Sander Piersma, Thang V. Pham, Connie R. Jimenez, Jaco C. Knol, Wim J. P. van Boven, Antoine H. G. Driessen, Tim A. C. de Vries, Britt van der Leeden, Hans W. M. Niessen, Onno J. de Boer, Sébastien P. J. Krul, Joris R. de Groot
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Epicardial adipose tissue (EAT) secretome induces fibrosis. Fibrosis, primarily extracellular matrix (ECM) produced by fibroblasts, creates a substrate for atrial fibrillation (AF). Whether the EAT secretome from patients with AF
Externí odkaz:
https://doaj.org/article/b6cf7114ad5148eaab99d938a3be13c0
Autor:
Martijn Beudel, Martin E W Hemels, Auke C Reidinga, Tom Dormans, Joris R de Groot, Suat Simsek, Kees Brinkman, Daisy Rusch, Renee A Douma, Niels C Gritters van den Oever, Brent Appelman, Jocelyn R Spruit, René W M M Jansen, Tim A C de Vries, Lianne R de Haan, Hazra S Moeniralam, Martijn de Kruif, Robert J Schuurman
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Objectives The aim of this multicentre COVID-PREDICT study (a nationwide observational cohort study that aims to better understand clinical course of COVID-19 and to predict which COVID-19 patients should receive which treatment and which type of car
Externí odkaz:
https://doaj.org/article/621ce08ddc714e549f9797523c01bbf4
Autor:
Robin Wesselink, Bente Mossink, Eva R. Meulendijks, Nicoline W. E. van den Berg, Jolien Neefs, Makiri Kawasaki, Benedetta Fabrizi, Femke R. Piersma, Rushd F. M. Al-Shama, Tim A. C. de Vries, Jonas S. S. G. de Jong, Wim Jan P. van Boven, Antoine H. G. Driessen, Joris R. de Groot
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 7; Pages: 2650
Journal of clinical medicine, 12(7):2650. Multidisciplinary Digital Publishing Institute (MDPI)
Journal of clinical medicine, 12(7):2650. Multidisciplinary Digital Publishing Institute (MDPI)
Introduction. Atrial fibrillation (AF) is more prevalent in men than in women. However, women with AF are more symptomatic, have a worse quality of life, a higher stroke risk and may therefore benefit most from ablation. In this study we aim to ident
Autor:
Patrizio Lancellotti, Georges H. Mairesse, Carlo de Asmundis, Martin E.W. Hemels, Frank Cools, Paulus Kirchhof, Joris R. de Groot, Tim A. C. de Vries, Ruben Casado Arroyo, Emmanuel Catez, Ivan Blankoff, Michel De Pauw, Peter Vanacker, Raffaele De Caterina, Laetitia Yperzeele, Anne de Veer, ETNA-AF-Europe principal investigators from Belgium, Harry J G M Crijns, Thomas Vanassche
Publikováno v:
Netherlands heart journal
Acta Cardiologica, 76, 4, pp. 431-439
Acta Cardiologica, 76(4), 431-439. Routledge/Taylor & Francis Group
Netherlands Heart Journal
Netherlands Heart Journal, 29, 158-167
Acta cardiologica
Netherlands heart journal, 29(3), 158-167. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29(3), 158-167. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29, 3, pp. 158-167
Acta Cardiologica, 76, 431-439
Acta Cardiologica, 76, 4, pp. 431-439
Acta Cardiologica, 76(4), 431-439. Routledge/Taylor & Francis Group
Netherlands Heart Journal
Netherlands Heart Journal, 29, 158-167
Acta cardiologica
Netherlands heart journal, 29(3), 158-167. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29(3), 158-167. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29, 3, pp. 158-167
Acta Cardiologica, 76, 431-439
Background: Studies on the use of non-vitamin K antagonist oral anticoagulants in unselected patients with atrial fibrillation (AF) show that clinical characteristics and dosing practices differ per region, but lack data on edoxaban. Methods: With da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abc05d62b3509fc548cf01f1cee1d2a
Autor:
Tim A. C. de Vries, Jeffrey S. Ginsberg, Imaad Mallick, Noel C. Chan, John W. Eikelboom, Paul C Kruger, Vinai Bhagirath, Jack Hirsh, Ke Xu
Publikováno v:
Thrombosis and haemostasis. 120(9)
Background Recent reports suggest an important contribution from frequent off-label use of apixaban 2.5 mg twice daily to the higher rates of thromboembolic events observed in observational studies (OSs) relative to in randomized controlled trials (R
Autor:
Jeffrey S. Ginsberg, Vinai Bhagirath, Tim A. C. de Vries, John W. Eikelboom, Ke Xu, Noel C. Chan, Paul C Kruger, Brian Dale, Jack Hirsh
Publikováno v:
Thrombosis and Haemostasis. 118:1895-1901
Background Ticagrelor is an anti-platelet agent that is indicated for prevention of thrombosis after acute coronary syndrome or intra-coronary artery stent implantation, but it increases the risk of bleeding. Platelet transfusion has the potential to
Autor:
Noel C. Chan, Jeffrey S. Ginsberg, Vinai Bhagirath, Tim A. C. de Vries, John W. Eikelboom, Jack Hirsh
Publikováno v:
Journal of the American College of Cardiology, 76(24), 2906-2907. Elsevier USA
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 56:772-773